Burning Rock Biotech

Burning Rock Biotech is a Guangdong Province, China-based company that provides next-generation sequencing diagnostic solutions for precision medicine in oncology. The organization develops genetic tests to guide individualized cancer treatments, offering 32 distinct products for various cancer types and clinical applications. Operating with a workforce of 501 to 1,000 employees, the firm functions both as a diagnostic testing service provider and a platform solution vendor for hospital pathology laboratories. Its client base includes over 300 top provincial and national hospitals across China, supported by strategic collaborations with major diagnostic equipment manufacturers such as Agilent, PerkinElmer, Illumina, and Qiagen. The enterprise also operates China's first CLIA-certified laboratory for both circulating tumor DNA and tissue assays while holding the country's first NMPA-approved sequencing kit. Burning Rock Biotech was founded in 2014 by Yusheng Han.